Skip to content

AptarGroup ATR Financing Cash Flow

Financing Cash Flow at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
-$308.7M-110%
Amcor logo
AmcorAMCR
$528M-66.8%
Nordson logo
NordsonNDSN
-$176.55M-55.9%
Baxter International logo
Baxter InternationalBAX
-$11M+99.7%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
-$1.61M+51.4%
AVT
AvantorAVTR

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's financing cash flow?
AptarGroup (ATR) reported financing cash flow of -$230.34M in Q1 2026.
How has AptarGroup's financing cash flow changed year-over-year?
AptarGroup's financing cash flow decreased by 70.9% year-over-year, from -$134.78M to -$230.34M.
What is the long-term trend for AptarGroup's financing cash flow?
Over 2 years (2022 to 2024), AptarGroup's financing cash flow has grown at a 17.9% compound annual growth rate (CAGR), from -$162.1M to -$225.34M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.